Ondine Biomedical Strengthens Leadership Team with the Appointment of Michael Behlke as non-Board CFO & COO
Ondine Biomedical Strengthens Leadership Team with the Appointment of Michael Behlke as non-Board CFO & COO
Shares of Ondine Biomedical Inc. saw an increase on Friday afternoon following the announcement that the company will be raising funds to advance the commercialization of its primary antimicrobial treatment.